ClinicalTrials.gg
Drug

Doravirine clinical trials

Also written MK-1439 and Pifeltro.

studies test it
36
open now
9
in phase 3
8
first study started
2011

Counted the way a researcher would: Doravirine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses doravirine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the doravirine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Aug 2018 · PIFELTRO · NDA 210806 (FDA, Drugs@FDA)
European Union
22 Nov 2018 · Delstrigo · EMEA/H/C/004746 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Doravirine
17
Doravirine 100Mg Tab
2
Doravirine 100 Mg
2
DOR
2
Doravirine (DOR)
2

Brand

Pifeltro
5

Development codes

MK-1439
12

In one entry with another drug

Given together, or one or the other

DOR/ISL
2
Doravirine/Lamivudine/Tenofovir
2
Doravirine, Tenofovir, Lamivudine
2
Doravirine + tenofovir DF + lamivudine
2

Studies by the year they started

36 studies that test it; most in 2020 (5)

Studies that test doravirine, by start year
YearStudies
20111
20121
20142
20154
20162
20171
20181
20192
20205
20214
20224
20232
20242
20253
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
11
Phase 2
9
Phase 3
8
Phase 4
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 15 · Other 21

Merck Sharp & Dohme LLC (15) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (3) · Chelsea and Westminster NHS Foundation Trust (2) · Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida (2) · Fundacion Clinic per a la Recerca Biomédica (1) · University of North Carolina, Chapel Hill (1) · Radboud University Medical Center (1) · University of Texas Southwestern Medical Center (1)

Often tested with

Tested in the same studies.

Lamivudine (9) · Tenofovir (8) · Islatravir (4) · Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (2) · Bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1) · Spironolactone (1) · Estradiol (1) · Rifapentine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test doravirine, phase 3 first.

Studies

Open first, then newest update. How each study uses doravirine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 36

See all 36 studies that test doravirine →

Given beside what is tested · 9 — doravirine is usual care or a partner of the new treatment

Codes

What other systems call doravirine · ClinicalTrials.gg INT000104

  • MeSH (NLM) C000592662doravirineOne source NLM
  • UNII (FDA) 913P6LK81MDORAVIRINEConfirmed FDA, NLM, Wikidata
  • RxNorm 2055755Confirmed FDA, Wikidata
  • Wikidata Q6885419doravirineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C171848DoravirineOne source FDA
  • DrugBank DB12301One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.